APA (7th ed.) Citation

Galbraith, K., Garcia, M., Wei, S., Chen, A., Schroff, C., Serrano, J., . . . Snuderl, M. (2024). Prognostic value of DNA methylation subclassification, aneuploidy, and CDKN2A/B homozygous deletion in predicting clinical outcome of IDH mutant astrocytomas. Neuro-Oncology, 26(6), . https://doi.org/10.1093/neuonc/noae009

Chicago Style (17th ed.) Citation

Galbraith, Kristyn, et al. "Prognostic Value of DNA Methylation Subclassification, Aneuploidy, and CDKN2A/B Homozygous Deletion in Predicting Clinical Outcome of IDH Mutant Astrocytomas." Neuro-Oncology 26, no. 6 (2024). https://doi.org/10.1093/neuonc/noae009.

MLA (9th ed.) Citation

Galbraith, Kristyn, et al. "Prognostic Value of DNA Methylation Subclassification, Aneuploidy, and CDKN2A/B Homozygous Deletion in Predicting Clinical Outcome of IDH Mutant Astrocytomas." Neuro-Oncology, vol. 26, no. 6, 2024, https://doi.org/10.1093/neuonc/noae009.